- Home
- CLDI vs SOS Comparison
CLDI vs SOS Comparison
Compare CLDI & SOS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | CLDI | SOS |
|---|---|---|
| Founded | 2014 | 2004 |
| Country | United States | China |
| Employees | N/A | N/A |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | Finance: Consumer Services |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 9.2M | 10.7M |
| IPO Year | N/A | 2017 |
Fundamental Metrics
Financial Performance| Metric | CLDI | SOS |
|---|---|---|
| Price | $1.15 | $1.62 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | ★ 69.6K | 65.8K |
| Earning Date | 11-13-2025 | 09-26-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | N/A | ★ $260,505,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | ★ 134.43 |
| 52 Week Low | $1.10 | $1.02 |
| 52 Week High | $19.20 | $9.62 |
Technical Indicators
Market Signals| Indicator | CLDI | SOS |
|---|---|---|
| Relative Strength Index (RSI) | 36.27 | 58.21 |
| Support Level | $1.12 | $1.54 |
| Resistance Level | $1.23 | $1.65 |
| Average True Range (ATR) | 0.07 | 0.17 |
| MACD | -0.01 | 0.01 |
| Stochastic Oscillator | 10.52 | 55.32 |
Price Performance
Historical ComparisonAbout CLDI Calidi Biotherapeutics Inc.
Calidi Biotherapeutics Inc is a clinical-stage immuno-oncology company with technology designed to arm the immune system to fight cancer. The Company's stem cell-based platforms utilize potent allogeneic stem cells capable of carrying payloads of oncolytic viruses for use in a many oncology indications, including high-grade gliomas and solid tumors. Its products include CLD-101 for Recurrent HGG; CLD-201 for Solid Tumors, and CLD-400 for certain lung cancer and Metastatic Solid Tumors. In addition to its pipeline products, the Company's is also engaged in discovery research of CLD-301 (AAA) for tumor Indications.
About SOS SOS Limited
SOS Ltd is a multifaceted company that leverages the power of data to provide marketing solutions, while also participating in the burgeoning fields of blockchain and cryptocurrency operations, as well as commodity trading. Its product offerings are diversified across four main areas: commodity trading, insurance marketing, cryptocurrency mining, and other services. The company has three reporting segments: Commodity trading, Cryptocurrency mining, and Others. Key revenue is generated from Commodity trading.